(Q35198032)

7 August 2017

1 reference

title

Research applications and implications of adenosine in diseased airways (English)

1 reference

7 August 2017

Lucia Spicuzza

1

1 reference

7 August 2017

Caterina Bonfiglio

series ordinal

2

1 reference

7 August 2017

Riccardo Polosa

series ordinal

3

1 reference

7 August 2017

publication date

1 August 2003

1 reference

Trends in Pharmacological Sciences

7 August 2017

published in

1 reference

7 August 2017

volume

24

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

409-413

1 reference

Adenosine in bronchoalveolar lavage fluid in asthma

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Adenosine receptors: G protein-mediated signalling and the role of accessory proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Provocation with adenosine 5'-monophosphate as a marker of inflammation in asthma, allergic rhinitis and chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5'-monophosphate in nonatopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Effect of indomethacin on adenosine-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5'-monophosphate and histamine in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Protective effect of oral terfenadine and not inhaled ipratropium on adenosine 5'-monophosphate-induced bronchoconstriction in patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

The role of adenosine as a novel bronchoprovocant in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Mast-cell infiltration of airway smooth muscle in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Histamine release upon adenosine 5'-monophosphate (AMP) nasal provocation in allergic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Adenosine A2B receptors: a novel therapeutic target in asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Concentrations of exhaled nitric oxide in asthmatics and subjects with allergic rhinitis sensitized to the same pollen allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjögren's syndrome. BHR Study Group. Bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Airway inflammation is present during clinical remission of atopic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Greater effect of inhaled budesonide on adenosine 5'-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Combined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Effect of cigarette smoking on airway responsiveness to adenosine 5'-monophosphate in subjects with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Airway inflammation and hyperresponsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Corticosteroid reversibility in COPD is related to features of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2803%2900193-7

7 January 2021

10.1016/S0165-6147(03)00193-7

Identifiers

DOI

1 reference

7 August 2017

1 reference